|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 38/31 | (2013.01) | ||
| A61K 38/31 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 9/0024 | (2013.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61K 47/12 | (2013.01) | ||
| A61K 47/22 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 5/02 | (2018.01) | ||
| A61P 5/04 | (2018.01) | ||
| A61P 5/08 | (2018.01) | ||
| A61K 38/08 | (2013.01) | ||
| A61K 38/12 | (2013.01) |
| (11) | Patento numeris | 3035912 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14736812.0 |
| Europos patento paraiškos padavimo data | 2014-07-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/064586 |
| Data | 2014-07-08 |
| (87) | Numeris | WO 2015/004125 |
| Data | 2015-01-15 |
| (30) | Numeris | Data | Šalis |
| 13290156 | 2013-07-09 | EP |
| (72) |
BIELSA GUIVERNAU, Ruth , ES
CHERIF-CHEIKH, Roland , ES
FOURNES, Julie , ES
MARTINEZ LORENTE, Daniel , ES
PETIT, Anne , FR
RICHARD, Joël , FR
|
| (73) |
IPSEN PHARMA S.A.S. ,
65, quai Georges Gorse, 91200 Boulogne-Billancourt,
FR
|
| (54) | PHARMACEUTICAL COMPOSITION FOR A SUSTAINED RELEASE OF LANREOTIDE |
| PHARMACEUTICAL COMPOSITION FOR A SUSTAINED RELEASE OF LANREOTIDE |